RC18

RC18 · RemeGen Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for RC18, covering 2020-03-04 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial [Phase 2]